Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors

被引:10
|
作者
Ye, Xiaocong M. [1 ]
Konradi, Andrei W. [1 ]
Sun, Minghua [1 ]
Yuan, Shendong [1 ]
Aubele, Danielle L. [1 ]
Dappen, Michael [1 ]
Dressen, Darren [1 ]
Garofalo, Albert W. [1 ]
Jagodzinski, Jacek J. [1 ]
Latimer, Lee [1 ]
Probst, Gary D. [1 ]
Sham, Hing L. [1 ]
Wone, David [1 ]
Xu, Ying-zi [1 ]
Ness, Daniel [2 ]
Brigham, Elizabeth [2 ]
Kwong, Grace T. [2 ]
Willtis, Chris [2 ]
Tonn, George [3 ]
Goldbach, Erich [3 ]
Quinn, Kevin P. [3 ]
Zhang, Hongbin H. [3 ]
Sauer, John-Michael [3 ]
Bova, Michael [4 ]
Basi, Guriqbal S. [5 ]
机构
[1] Elan Pharmaceut, Dept Med Chem, San Francisco, CA 94080 USA
[2] Elan Pharmaceut, Dept Pharmacol, San Francisco, CA 94080 USA
[3] Elan Pharmaceut, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA
[4] Elan Pharmaceut, Dept Assay Dev, San Francisco, CA 94080 USA
[5] Elan Pharmaceut, Dept Biol, San Francisco, CA 94080 USA
关键词
Alzheimer's disease; Amyloid precursor protein; gamma-Secretase; gamma-Secretase inhibitor; Notch; ALZHEIMERS-DISEASE; GENES;
D O I
10.1016/j.bmcl.2012.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-activity relationship (SAR) of a novel, potent and metabolically stable series of benzo [3.2.1] bicyclic sulfonamide-pyrazoles as gamma-secretase inhibitors are described. Compounds that are efficacious in reducing the cortical A beta x-40 levels in FVB mice via oral dose, as well as those with high selectivity over Notch, are highlighted. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:996 / 1000
页数:5
相关论文
共 50 条
  • [31] Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors
    Tong, Yunsong
    Claiborne, Akiyo
    Stewart, Kent D.
    Park, Chang
    Kovar, Peter
    Chen, Zehan
    Credo, Robert B.
    Gu, Wen-Zhen
    Gwaltney, Stephen L., II
    Judge, Russell A.
    Zhang, Haiying
    Rosenberg, Saul H.
    Sham, Hing L.
    Sowin, Thomas J.
    Lin, Nan-horng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) : 2759 - 2767
  • [32] Discovery of a potent, selective, and efficacious class of reversible α-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics
    Boger, DL
    Miyauchi, H
    Du, W
    Hardouin, C
    Fecik, RA
    Cheng, H
    Hwang, I
    Hedrick, MP
    Leung, D
    Acevedo, O
    Guimaraes, CRW
    Jorgensen, WL
    Cravatt, BF
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1849 - 1856
  • [33] Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
    Soldermann, Carole Pissot
    Simic, Oliver
    Renatus, Martin
    Erbel, Paulus
    Melkko, Samu
    Wartmann, Markus
    Bigaud, Marc
    Weiss, Andreas
    McSheehy, Paul
    Endres, Ralf
    Santos, Paulo
    Blank, Jutta
    Schuffenhauer, Ansgar
    Bold, Guido
    Buschmann, Nicole
    Zoller, Thomas
    Altmann, Eva
    Manley, Paul W.
    Dix, Ina
    Buchdunger, Elisabeth
    Scesa, Julien
    Quancard, Jean
    Schlapbach, Achim
    Bornancin, Frederic
    Radimerski, Thomas
    Regnier, Catherine H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14576 - 14593
  • [34] Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
    Shenghua Gao
    Letian Song
    Yusen Cheng
    Fabao Zhao
    Dongwei Kang
    Shu Song
    Mianling Yang
    Bing Ye
    Wei Zhao
    Yajie Tang
    Erik De Clercq
    Christophe Pannecouque
    Peng Zhan
    Xinyong Liu
    Acta Pharmaceutica Sinica B, 2023, (06) : 2747 - 2764
  • [35] Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
    Gao, Shenghua
    Song, Letian
    Cheng, Yusen
    Zhao, Fabao
    Kang, Dongwei
    Song, Shu
    Yang, Mianling
    Ye, Bing
    Zhao, Wei
    Tang, Yajie
    De Clercq, Erik
    Pannecouque, Christophe
    Zhan, Peng
    Liu, Xinyong
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (06) : 2747 - 2764
  • [36] Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors
    Patel, Dipam
    Jain, Mukul
    Shah, Shailesh R.
    Bahekar, Rajesh
    Jadav, Pradip
    Joharapurkar, Amit
    Dhanesha, Nirav
    Shaikh, Mubeen
    Sairam, Kalapatapu V. V. M.
    Kapadnis, Prashant
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1111 - 1117
  • [37] MEDI 365-Discovery of ß-sulfonamide piperidine hydroxamates as potent and selective HER-2 sheddase inhibitors
    Burns, David M.
    He, Chunhong
    Li, Yanlong
    Scherle, Peggy
    Covington, Maryanne
    Pan, Max
    Wynn, Richard
    Turner, Sharon
    Fridman, Jordan S.
    Friedman, Steve
    Metcalf, Brian
    Yao, Wenqing
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [38] Discovery and characterization of novel, highly potent and selective USP7 inhibitors
    Gavory, Gerald
    O'dowd, Colin
    McClelland, Keeva
    Odrzywol, Ewa
    Brown, Alan
    Burton, Stephanie
    Barker, Oliver
    Burkamp, Frank
    Heim, Matt
    James, Iain
    Flasz, Jakub
    Arkoudis, Elias
    Harrison, Tim
    CANCER RESEARCH, 2015, 75
  • [39] Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors
    Pinard, Emmanuel
    Alberati, Daniela
    Borroni, Edilio
    Fischer, Holger
    Hainzl, Dominik
    Jolidon, Synese
    Moreau, Jean-Luc
    Narquizian, Robert
    Nettekoven, Matthias
    Norcross, Roger D.
    Stalder, Henri
    Thomas, Andrew W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (18) : 5134 - 5139
  • [40] Discovery of a novel class of nonsteroidal, potent and selective 11β-hydroxysteroid dehydrogenase inhibitors
    Willemsens, S
    Linders, J
    Hrupka, B
    Smans, K
    Bellens, D
    De Backker, P
    Van Dorsselaer, P
    Jaroskova, L
    Van der Veken, L
    Gilissen, R
    Berwaer, M
    OBESITY RESEARCH, 2004, 12 : A1 - A1